AX213 and AX132 PCSK9 antagonists and variants

Details for Australian Patent Application No. 2010313324 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Luo, Peter Peizhi; Ni, Yan; Wang, Kevin Caili; Hsieh, Mark; Wang, Xinwei; Dong, Feng; Golosov, Andrei; Wang, Weirong; Li, Yan; Zhong, Pingyu; Peterson, Laurence B.; Cubbon, Rose; Sharma, Sujata; Condra, Jon; Lu, Jun; Parthasarathy, Gopalakrishnan; Soisson, Stephen; Byrne, Noel

Agent Spruson & Ferguson

Pub. Number AU-A-2010313324

PCT Pub. Number WO2011/053783

Priority 61/256,732 30.10.09 US; 61/323,148 12.04.10 US

Filing date 29 October 2010

Wipo publication date 5 May 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/053783 Priority application(s): WO2011/053783

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010313334-A food product pertaining to a fillingand-cracker sandwich

2010313323-Direct control spinal implant